Back

Can donor hearts survive 24 hours of hypothermic oxygenated machine perfusion before transplantation?

20 March 2026 (08:30 - 09:30)
Organised by: Logo
Congress Presentation Part of: The operating theatre: optimising interventions in acute cardiac care Treatment ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Maja B Thomassen

Institute of Clinical Medicine, Aarhus N (Denmark)

7 More presentations in this session

Presentation thumbnail
The effect of Levosimendan in weaning from veno-arterial extracorporeal membrane oxygenation in patients with postcardiotomy shock
Doctor Z. Dietze (Leipzig, DE)
Abstract
Presentation thumbnail
Heart transplantation in patients transferred after emergent VA-ECMO from local secondary hospitals: a single-center experience in Korea
Doctor J. Hong (Seoul, KR)
Abstract
Presentation thumbnail
Rising pericardial effusion burden and procedural shifts in the US
Doctor B. Cohen (Bethlehem, US)
Abstract
Presentation thumbnail
Differential impact of pre-transplant hemodynamic optimization strategies on postoperative extracardiac outcomes
Assistant Professor A. Rali (Nashville, US)
Abstract
Presentation thumbnail
Effects of inhaled nitric oxide on the pulmonary circulatory system in a porcine model of heart transplantation.
Sir K. Lenbroch (Aarhus, DK)
Abstract

Access the full session

Session thumbnail
The operating theatre: optimising interventions in acute cardiac care

The Event

Event poster

ESC Acute CardioVascular Care 2026

20 March 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Crystalloid Custodiol based ex vivo perfusion demonstrates comparable efficacy to blood perfusion in a clinically relevant DCD heart transplantation large animal model
thumbnail
Congress Presentation
Heart transplantation in patients transferred after emergent VA-ECMO from local secondary hospitals: a single-center experience in Korea
thumbnail
Congress Presentation
24 hours of hypothermic oxygenated perfusion mitigates transcriptomic remodeling in DCD and DBD hearts, supporting successful transplantation outcomes

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources